Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
Open accessAbstract
Advances in the understanding of multiple sclerosis and the development of biomarkers of pathophysiology prompted a substantial revision of the 2017 McDonald diagnostic criteria. The new 2024 McDonald criteria provide a unified approach for diagnosing multiple sclerosis in individuals with relapsing or progressive courses throughout the lifespan (ie, from paediatric to late-life presentations). The optic nerve can now serve as a fifth anatomical location within the CNS for diagnosis. The central vein sign, paramagnetic rim lesions, and kappa free-light chain concentrations in CSF can be used, when available, to provide supportive evidence and confer specificity for a diagnosis of multiple sclerosis in specific situations. In certain cases, radiologically isolated syndrome or neurological symptoms that do not constitute a clear attack or progression of disability can fulfil the criteria for a multiple sclerosis diagnosis. We also provide guidance for the diagnosis of multiple sclerosis in older individuals (≥50 years) and those with comorbidities. The 2024 revised criteria should expedite the diagnosis of multiple sclerosis, while maintaining specificity.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In multiple sclerosis, the McDonald criteria are the standard criteria for disease diagnosis; according to these criteria, patients must present with multiple lesions in the central nervous system that are disseminated in space.
“In MS, the McDonald criteria are the standard criteria for disease diagnosis. According to these criteria, patients must present with multiple lesions in the central nervous system (CNS) that are disseminated in space (Montalban et al. 2025).”
From The Prevalence of Neuropathic Pain in Multiple Sclerosis—A Systematic Review and Meta‐Analysis Using the <scp>NeuPSIG</scp> Algorithm (2026) · cites this paper as Montalban et al. 2025
The indexed title identifies the McDonald criteria as criteria for diagnosing multiple sclerosis. However, the available passages contain only title and citation metadata; they do not establish that the criteria are the standard or that patients must have multiple CNS lesions disseminated in space. Searches for dissemination in space and lesion locations found no passage stating those requirements. (LLM, conf=0.70)
Experimental — accuracy not yet measuredThe 2024 revisions aim to increase diagnostic sensitivity while incorporating additional features intended to preserve, even increase, diagnostic specificity, thereby enabling an earlier and more accurate diagnosis of MS.
“These revisions aim to increase diagnostic sensitivity while incorporating additional features intended to preserve, even increase, diagnostic specificity, thereby enabling an earlier and more accurate diagnosis of MS.8”
From Applying the 2024-revised McDonald criteria for multiple sclerosis using conventional diagnostic tools: a single-centre prospective cohort study in Germany (2026) · cites this paper as [8]
The indexed Abstract says the 2024 criteria should expedite MS diagnosis while maintaining specificity, and identifies additional features that can confer specificity in specific situations. It does not say that the revisions aim to increase specificity or explicitly claim increased diagnostic sensitivity or accuracy. (LLM, conf=0.83)
Experimental — accuracy not yet measuredThe 2024 revisions of the McDonald diagnostic criteria for multiple sclerosis include the optic nerve as a distinct fifth anatomical location for meeting dissemination in space criteria for relapsing- and progressive-onset MS.
“The committee voted unanimously to include the optic nerve as a distinct, fifth anatomical location for meeting dissemination in space (DIS) criteria for relapsingand progressive-onset MS. 25”
From The use of optical coherence tomography and visual evoked potentials in the 2024 McDonald diagnostic criteria for multiple sclerosis (2025) · cites this paper as [25]
The indexed Abstract (page unavailable) says the 2024 criteria cover relapsing and progressive courses and that the optic nerve can serve as a fifth anatomical location for diagnosis. It does not state that the committee voted unanimously, as the citing sentence claims. (LLM, conf=0.83)
Experimental — accuracy not yet measuredIn the 2024 McDonald criteria for multiple sclerosis diagnosis, the optic nerve is added to the four previously designated dissemination-in-space regions (periventricular, juxtacortical/cortical, infratentorial, spinal cord), and dissemination-in-space criteria can be met with involvement of at least 2 of these 5 regions.
“In the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis, the optic nerve is added to the four previously designated DIS regions: peri-ventricular, juxta-cortical/cortical, infra-tentorial and spinal cord regions. DIS criteria for MS diagnosis can now be met with involvement of ≥ 2/5 of these regions (Panel 1). 25,26”
From The use of optical coherence tomography and visual evoked potentials in the 2024 McDonald diagnostic criteria for multiple sclerosis (2025) · cites this paper as [25]
Split into 2 atoms — 1 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredThe optic nerve is incorporated as the fifth neuroanatomical topography for establishing DIS in the 2024-revised McDonald criteria.
“The optic nerve is incorporated as the fifth neuroanatomical topography for establishing DIS, complementing periventricular, (juxta-)cortical, infratentorial, and spinal cord regions.8, 9, 10”
The 2024 revision introduces substantial modifications that reflect advances in neuroimaging, neurophysiological assessment, and biomarker discovery.
“The 2024 revision introduces substantial modifications that reflect advances in neuroimaging, neurophysiological assessment, and biomarker discovery.8”
From Applying the 2024-revised McDonald criteria for multiple sclerosis using conventional diagnostic tools: a single-centre prospective cohort study in Germany (2026) · cites this paper as [8]
The available indexed passages identify the paper as addressing the 2024 revisions, but contain only a title, author list, and bibliographic information (labelled Abstract; no page given). Searches for neuroimaging, neurophysiological assessment, and biomarkers found no passage describing the revisions or what informed them, so the claim cannot be checked against our copy. (LLM, conf=0.72)
Experimental — accuracy not yet measuredIn CSF, intrathecal inflammation can be demonstrated by oligoclonal bands (OCB) or by kappa free light chains (KFLC).
“in CSF, intrathecal inflammation can be demonstrated by oligoclonal bands (OCB) or by kappa free light chains (KFLC), which represent a complementary biomarker.8, 9, 10, 11, 12”
From Applying the 2024-revised McDonald criteria for multiple sclerosis using conventional diagnostic tools: a single-centre prospective cohort study in Germany (2026) · cites this paper as [8]
The available indexed passages contain bibliographic information but no discussion of CSF biomarkers. Searches for oligoclonal bands, kappa free light chains, and intrathecal antibody synthesis found no passage that addresses the claim. (LLM, conf=0.70)
Experimental — accuracy not yet measuredOptic nerve involvement can be substantiated by VEP, OCT, or MRI in the 2024-revised criteria.
“Optic nerve involvement can be substantiated by visual evoked potentials (VEP), optical coherence tomography (OCT), or MRI thus formally integrating visual pathway assessment into the diagnostic framework.8, 9, 10”
From Applying the 2024-revised McDonald criteria for multiple sclerosis using conventional diagnostic tools: a single-centre prospective cohort study in Germany (2026) · cites this paper as [8]
The supplied passages and indexed results contain bibliographic information, not the criteria's provisions on optic nerve involvement. Searches for visual evoked potentials, optical coherence tomography, MRI, and optic nerve involvement returned no passage addressing whether these methods substantiate involvement under the 2024 revisions. (LLM, conf=0.73)
Experimental — accuracy not yet measuredThe 2024-revised criteria permit a diagnosis of MS in individuals with RIS and in people with non-specific presentations.
“Lastly, the criteria now permit a diagnosis of MS in individuals with incidental MRI findings suggestive of chronic inflammatory demyelination (RIS: radiologically isolated syndrome) and in people with non-specific presentations.8,13”
From Applying the 2024-revised McDonald criteria for multiple sclerosis using conventional diagnostic tools: a single-centre prospective cohort study in Germany (2026) · cites this paper as [8]
The supplied passages contain bibliographic information, and searches for radiologically isolated syndrome, nonspecific symptoms, and incidental MRI findings returned no relevant full-text section or page. The only passage addressing diagnosis in these groups is labelled Abstract, which is not admissible evidence under the stated rubric. (LLM, conf=0.65)
Experimental — accuracy not yet measuredUnder the 2024-revised criteria, MS can be diagnosed when ≥4 typical topographies are affected.
“MS can be diagnosed when ≥4 typical topographies are affected.8, 9, 10”
From Applying the 2024-revised McDonald criteria for multiple sclerosis using conventional diagnostic tools: a single-centre prospective cohort study in Germany (2026) · cites this paper as [8]
The passages available from our copy contain bibliographic information, but no diagnostic rule. Searches for four typical topographies and for four of five anatomical locations found no passage addressing the claimed threshold, so our copy cannot verify it. (LLM, conf=0.72)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802 · see citing works
Self-citationMultiple sclerosis progression: time for a new mechanism-driven framework
Kuhlmann, T., Moccia, M., Coetzee, T., Cohen, J. A., Correale, J., Graves, J., Marrie, R. A., Montalban, X., Yong, V. W., Thompson, A. J., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00289-7 · Cited by 667 · see citing works
Self-citationThe contemporary spectrum of multiple sclerosis misdiagnosis
Solomon, A. J., Bourdette, D. N., Cross, A. H., Applebee, A., Skidd, P. M., Howard, D. B., Spain, R. I., Cameron, M. H., Kim, E., Mass, M. K., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003152 · Cited by 334 · see citing works
Self-citationVidal-Jordana, A., Rovira, A., Calderon, W., Arrambide, G., Castilló, J., Moncho, D., Rahnama, K., Collorone, S., Toosy, A. T., Ciccarelli, O., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000207805 · Cited by 88 · see citing works
Self-citationSaidha, S., Green, A. J., Leocani, L., Vidal-Jordana, A., Kenney, R. C., Bsteh, G., Outteryck, O., Thompson, A., Montalban, X., Coetzee, T., et al. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00275-3 · Cited by 66 · see citing works
Self-citationFreedman, M. S., Thompson, E. J., Deisenhammer, F., Giovannoni, G., Grimsley, G., Keir, G., Öhman, S., Racke, M. K., Sharief, M., Sindic, C. J. M., et al. (2005) · Archives of Neurology · doi:10.1001/archneur.62.6.865 · Cited by 41 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Saidha, S., Green, A. J., Leocani, L., Vidal-Jordana, A., Kenney, R. C., Bsteh, G., Outteryck, O., Thompson, A., Montalban, X., Coetzee, T., et al. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00275-3 · Cited by 66 · see citing works
Self-citationJungersen, R. C., Baccaro, V. K., Hvid, L. G., Dalgas, U., & Hoegh, M. (2026) · European Journal of Pain · doi:10.1002/ejp.70375 · Cited by 1 · see citing works
Konen, F. F., Mahmoudi, N., Albers, L. M., Arrambide, G., Streichert, A. L., Haar, M., Soldatov, A., Bucak, E., Jendretzky, K. F., Nay, S., et al. (2026) · eClinicalMedicine · doi:10.1016/j.eclinm.2026.104098
“8 The .”
InfluentialSelf-citationMendis, D. D., Vallamchetla, S. K., Marin Collazo, I. V., Sandhu, S. J. S., & Meschia, J. F. (2026) · Neurology Genetics · doi:10.1212/nxg.0000000000200430
- Authors
- Montalban, X., Lebrun-Frénay, C., Oh, J., Arrambide, G., Moccia, M., Pia Amato, M., Amezcua, L., Banwell, B., Bar-Or, A., Barkhof, F., Butzkueven, H., Ciccarelli, O., Chataway, J., Cohen, J. A., Comi, G., Correale, J., Deisenhammer, F., Filippi, M., Fiol, J., Freedman, M. S., Fujihara, K., Granziera, C., Green, A. J., Hartung, H.-P., Hellwig, K., Kappos, L., Kimbrough, D., Killestein, J., Lublin, F., Marignier, R., Ann Marrie, R., Miller, A., Otero-Romero, S., Ontaneda, D., Ramanathan, S., Reich, D., Rocca, M. A., Rovira, À., Saidha, S., Salter, A., Sastre-Garriga, J., Saylor, D., Solomon, A. J., Sormani, M. P., Stankoff, B., Tintore, M., Tremlett, H., Van der Walt, A., Viswanathan, S., Wiendl, H., Wildemann, B., Yamout, B., Zaratin, P., Calabresi, P. A., Coetzee, T., & Thompson, A. J.
- Affiliations
- St. Michael's Hospital (CA)
- Universitat Autònoma de Barcelona (ES)
- National Hospital for Neurology and Neurosurgery (GB)
- University of Southern California (US)
- Johns Hopkins University (US)
- The Alfred Hospital (AU)
- National Institute for Health and Care Research (GB)
- Cleveland Clinic (US)
- Vita-Salute San Raffaele University (IT)
- Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (AR)
- Innsbruck Medical University (AT)
- National Multiple Sclerosis Society (US)
- University of Ottawa (CA)
- Fukushima Medical University (JP)
- University of Basel (CH)
- University of California, San Francisco (US)
- The University of Sydney (AU)
- St. Josef-Hospital (DE)
- Duke University (US)
- Amsterdam University Medical Centers (NL)
- Icahn School of Medicine at Mount Sinai (US)
- Hospices Civils de Lyon (FR)
- National Institutes of Health (US)
- The University of Texas Southwestern Medical Center (US)
- University of North Carolina at Chapel Hill (US)
- University of Vermont (US)
- University of Genoa (IT)
- Sorbonne Université (FR)
- University of British Columbia (CA)
- Hospital Kuala Lumpur (MY)
- University Hospital Heidelberg (DE)
- University of Freiburg (DE)
- ORCID
- Oh, Jiwon
- Arrambide, Georgina
- Moccia, Marcello
- Amezcua, Lilyana
- Banwell, Brenda
- Barkhof, Frederik
- Butzkueven, Helmut
- Ciccarelli, Olga
- Chataway, Jeremy
- Cohen, Jeffrey A
- Correale, Jorge
- Deisenhammer, Florian
- Filippi, Massimo
- Fiol, Julie
- Fujihara, Kazuo
- Granziera, Cristina
- Green, Ari J
- Hellwig, Kerstin
- Kappos, Ludwig
- Kimbrough, Dorlan
- Killestein, Joep
- Lublin, Fred
- Marignier, Romain
- Miller, Aaron
- Ontaneda, Daniel
- Ramanathan, Sudarshini
- Reich, Daniel
- Rocca, Maria A
- Rovira, Àlex
- Saidha, Shiv
- Salter, Amber
- Saylor, Deanna
- Solomon, Andrew J
- Sormani, Maria Pia
- Stankoff, Bruno
- Tremlett, Helen
- Viswanathan, Shanthi
- Wiendl, Heinz
- Yamout, Bassem
- Zaratin, Paola
- Calabresi, Peter A
- Coetzee, Timothy
- Thompson, Alan J
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2025-10
- Volume
- 24
- Issue
- 10
- Pages
- 850-865
- ISSN
- 1474-4422 (ISSN-L)
- OpenAlex
- W4414272694
- Cited by
- 551
- References
- 6
- Citations by year
- 2026: 472 · 2025: 74 · 2024: 1 · 2019: 1
- FWCI
- 84.91
- Type
- journal article
- Language
- en
- Update notices
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion, cc-by-nc-nd)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- Funders
- European Committee for Treatment and Research in Multiple Sclerosis
- National Multiple Sclerosis Society
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
- Health Sciences › Medicine › Family Practice › Clinical Reasoning and Diagnostic Skills
- Keywords
- multiple sclerosis, McDonald criteria, diagnostic criteria revision, relapsing-remitting multiple sclerosis, secondary progressive multiple sclerosis, pediatric multiple sclerosis, optic nerve lesions, central vein sign, paramagnetic rim lesions, kappa free light chains, cerebrospinal fluid biomarkers, radiologically isolated syndrome, diagnostic specificity
- MeSH terms
- Humans, Magnetic Resonance Imaging, Multiple Sclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review